I actually feel full enrollment will be done before that. Knowledge about Leronlimab is starting to get to the right people . The 2 , soon to be 3 published papers will hit home in the medical community. Adding more locations for the trial as well as the UK just now getting spun up, I expect the enrollments to accelerate starting the week of Nov 9 th. Just 2 enrollments a day at that point gets us to full enrollment by early December. With Lilly, Regeneron, and the weakness of Gilead’s Remdisivir showing we aren’t making progress in fighting this disease, people who are desperate will be willing to sign up for the Leronlimab trial..there won’t be a lot of choices